Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Shares Outstanding (2020 - 2023)

Historic Shares Outstanding for Terns Pharmaceuticals (TERN) over the last 4 years, with Q3 2023 value amounting to $61.8 million.

  • Terns Pharmaceuticals' Shares Outstanding rose 6426.2% to $61.8 million in Q3 2023 from the same period last year, while for Sep 2023 it was $61.8 million, marking a year-over-year increase of 6426.2%. This contributed to the annual value of $53.7 million for FY2022, which is 11260.28% up from last year.
  • According to the latest figures from Q3 2023, Terns Pharmaceuticals' Shares Outstanding is $61.8 million, which was up 6426.2% from $61.1 million recorded in Q2 2023.
  • In the past 5 years, Terns Pharmaceuticals' Shares Outstanding ranged from a high of $61.8 million in Q3 2023 and a low of $215890.0 during Q1 2020
  • Moreover, its 4-year median value for Shares Outstanding was $25.3 million (2021), whereas its average is $28.2 million.
  • As far as peak fluctuations go, Terns Pharmaceuticals' Shares Outstanding skyrocketed by 1149930.43% in 2021, and later surged by 90.86% in 2022.
  • Over the past 4 years, Terns Pharmaceuticals' Shares Outstanding (Quarter) stood at $337508.0 in 2020, then soared by 7387.01% to $25.3 million in 2021, then surged by 112.6% to $53.7 million in 2022, then increased by 15.01% to $61.8 million in 2023.
  • Its Shares Outstanding stands at $61.8 million for Q3 2023, versus $61.1 million for Q2 2023 and $56.7 million for Q1 2023.